Literature DB >> 3681426

Drug cytotoxicity at elevated temperature. In vitro study on the U-87MG glioma cell line.

V F Da Silva1, G P Raaphorst, R Goyal, M Feeley.   

Abstract

The malignant glioma cell line U-87MG was used for 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), aziridinylbenzoquinone (AZQ), cis-diaminodichloroplatinum (II) (cis-DDP), and spirohydantoin mustard (SHM) treatments at 37 degrees and 42 degrees C. With the exception of SHM, all drugs killed a greater proportion of cells at the higher temperature, as assessed by the colony-formation assay. Drug-dose enhancement ratios were 1.6, 2.8, 2, and 1:1 for BCNU, AZQ, cis-DDP, and SHM, respectively. Because methods to heat discrete volumes of brain are now available, we conclude that hyperthermic increase of BCNU, AZQ, and cis-DDP cytotoxicity might have therapeutic application for malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681426     DOI: 10.3171/jns.1987.67.6.0885

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

Review 1.  Focal laser treatment in addition to chemotherapy for retinoblastoma.

Authors:  Ido D Fabian; Kenneth P Johnson; Andrew W Stacey; Mandeep S Sagoo; M A Reddy
Journal:  Cochrane Database Syst Rev       Date:  2017-06-07

2.  Sensitization to hyperthermia by intracellular acidification of C6 glioma cells.

Authors:  R Kitai; M Kabuto; T Kubota; H Kobayashi; H Matsumoto; S Hayashi; H Shioura; T Ohtsubo; K Katayama; E Kano
Journal:  J Neurooncol       Date:  1998-09       Impact factor: 4.130

3.  Hyperthermic potentiation of BCNU toxicity in BCNU-resistant human glioma cells.

Authors:  V F Da Silva; M Feeley; G P Raaphorst
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.